First-in-kind real-time pharmacokinetic data in a mouse tumor model confirmed WTX-124 selective activation in tumors, sparing healthy tissue WATERTOWN, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- ...
Participation in the Jefferies Global Healthcare Conference highlights Werewolf Therapeutics' commitment to engagement with the investment community and showcases its innovative approach to cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results